Sylvia R. Wheeler

Sylvia R.
Wheeler is currently the Director-West Coast Division at Advances In Kidney Disease & Health.
Former positions include Director-Corporate Communications at Cerus Corp.
(2003), Director-Corporate Communications at Coulter Pharmaceuticals, Inc. (2000), Senior Director-Corporate Communications at Assertio Therapeutics, Inc. (2007), Director-Corporate Relations & Planning at Connetics Corp.
(1995-1997), Director-Corporate Communications at Affymax, Inc. (2010-2011), Head-Investor Relations & Corporate Communications at Mereo BioPharma 5, Inc., VP-Investor Relations & Corporate Communications at Hyperion Therapeutics, Inc. (2013-2014), Senior VP-Investor Relations & Corporate Affairs at Aduro BioTech, Inc., VP-Investor Relations & Corporate Affairs at Relypsa, Inc., Investor Contact Relations at Immune Design Corp., and Investor Relations Contact at Rapt Therapeutics, Inc. Education includes undergraduate studies at San Francisco State University and an MBA from the University of San Francisco.